HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanjie Han Selected Research

Carcinogenesis

10/2019Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanjie Han Research Topics

Disease

3Neoplasms (Cancer)
02/2024 - 10/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 10/2019
1Colorectal Neoplasms (Colorectal Cancer)
02/2024
1Hepatitis
03/2023
1Ascites
10/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2019
1Carcinogenesis
10/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2019
1Lung Neoplasms (Lung Cancer)
10/2019
1Glioma (Gliomas)
06/2019

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
03/2023 - 10/2019
16-methyladenineIBA
02/2024
1EnzymesIBA
02/2024
1MethyltransferasesIBA
02/2024
1Biomarkers (Surrogate Marker)IBA
03/2023
1ErbB Receptors (EGF Receptor)IBA
01/2020
1gamma Catenin (Plakoglobin)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
10/2019
1Indicators and Reagents (Reagents)IBA
10/2019
1Pyruvate KinaseIBA
10/2019
1RNA Splicing FactorsIBA
10/2019
1Cytochromes c (Cytochrome c)IBA
10/2019
1Long Noncoding RNAIBA
06/2019

Therapy/Procedure

2Therapeutics
02/2024 - 01/2023
1Drug Therapy (Chemotherapy)
02/2024
1Immunotherapy
02/2024